Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:45:41.828Z.
Calculation as of: 2026-10-06T18:45:41.828Z.
Quote observation: 2026-10-06T18:45:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$33.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.58M
Operating Cash Flow Yield
N/A
TTM Avg
26.21%
3Y Avg
25.33%
5Y Avg
25.33%
Market Cap
$33.12M
Operating Cash Flow Yield
N/A
TTM Avg
13.07%
3Y Avg
8.54%
5Y Avg
8.65%
Market Cap
$34.42M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.19M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.57M
Operating Cash Flow Yield
N/A
TTM Avg
53.98%
3Y Avg
44.70%
5Y Avg
26.51%
Market Cap
$32.17M
Operating Cash Flow Yield
9.01%
TTM Avg
9.56%
3Y Avg
8.42%
5Y Avg
8.42%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $33.71M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | N/A | N/A | N/A | N/A |
| Scilex Holding Company (SCLX)vs › | $33.58M | N/A | 26.21% | 25.33% | 25.33% |
| Accuray Incorporated (ARAY)vs › | $33.12M | N/A | 13.07% | 8.54% | 8.65% |
| Elutia Inc (ELUT)vs › | $34.48M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.57M | N/A | 53.98% | 44.70% | 26.51% |
| Rockwell Medical, Inc. (RMTI)vs › | $32.17M | 9.01% | 9.56% | 8.42% | 8.42% |
| EUDA Health Holdings Limited (EUDA)vs › | $35.86M | N/A | 0.20% | 0.20% | 0.20% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
